Literature DB >> 25157106

First demonstration of transmissible spongiform encephalopathy-associated prion protein (PrPTSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification.

Paula Saá1, Oksana Yakovleva2, Jorge de Castro2, Irina Vasilyeva2, Silvia H De Paoli3, Jan Simak3, Larisa Cervenakova2.   

Abstract

The development of variant Creutzfeldt-Jakob disease (vCJD) in three recipients of non-leukoreduced red blood cells from asymptomatic donors who subsequently developed the disease has confirmed existing concerns about the possible spread of transmissible spongiform encephalopathies (TSEs) via blood products. In addition, the presence of disease-associated misfolded prion protein (PrP(TSE)), generally associated with infectivity, has been demonstrated in the blood of vCJD patients. However, its origin and distribution in this biological fluid are still unknown. Various studies have identified cellular prion protein (PrP(C)) among the protein cargo in human blood-circulating extracellular vesicles released from endothelial cells and platelets, and exosomes isolated from the conditioned media of TSE-infected cells have caused the disease when injected into experimental mice. In this study, we demonstrate the detection of PrP(TSE) in extracellular vesicles isolated from plasma samples collected during the preclinical and clinical phases of the disease from mice infected with mouse-adapted vCJD and confirm the presence of the exosomal marker Hsp70 in these preparations.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Blood; Cell Culture; Exosome; Extracellular Vesicles; Mouse

Mesh:

Substances:

Year:  2014        PMID: 25157106      PMCID: PMC4200276          DOI: 10.1074/jbc.M114.589564

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

1.  Cellular prion protein is released on exosomes from activated platelets.

Authors:  Catherine Robertson; Stephanie A Booth; Daniel R Beniac; Michael B Coulthart; Timothy F Booth; Archibald McNicol
Journal:  Blood       Date:  2006-01-24       Impact factor: 22.113

2.  Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.

Authors:  L Zitvogel; A Regnault; A Lozier; J Wolfers; C Flament; D Tenza; P Ricciardi-Castagnoli; G Raposo; S Amigorena
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

3.  Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

Authors:  Julie Ann Edgeworth; Michael Farmer; Anita Sicilia; Paul Tavares; Jonathan Beck; Tracy Campbell; Jessica Lowe; Simon Mead; Peter Rudge; John Collinge; Graham S Jackson
Journal:  Lancet       Date:  2011-02-05       Impact factor: 79.321

4.  Cellular prion protein is expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma.

Authors:  Jan Simák; Karel Holada; Felice D'Agnillo; Jan Janota; Jaroslav G Vostal
Journal:  Transfusion       Date:  2002-03       Impact factor: 3.157

5.  Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain.

Authors:  Jean-Philippe Brandel; Craig A Heath; Mark W Head; Etienne Levavasseur; Richard Knight; Jean-Louis Laplanche; Jan Pm Langeveld; James W Ironside; Jean-Jacques Hauw; Jan Mackenzie; Annick Alpérovitch; Robert G Will; Stéphane Haïk
Journal:  Ann Neurol       Date:  2009-03       Impact factor: 10.422

6.  A highly specific blood test for vCJD.

Authors:  Graham S Jackson; Jesse Burk-Rafel; Julie A Edgeworth; Anita Sicilia; Sabah Abdilahi; Justine Korteweg; Jonathan Mackey; Claire Thomas; Guosu Wang; Simon Mead; John Collinge
Journal:  Blood       Date:  2014-01-16       Impact factor: 22.113

Review 7.  Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.

Authors:  Anja Schneider; Mikael Simons
Journal:  Cell Tissue Res       Date:  2012-05-19       Impact factor: 5.249

8.  Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.

Authors:  Rocio Castro-Seoane; Holger Hummerich; Trevor Sweeting; M Howard Tattum; Jacqueline M Linehan; Mar Fernandez de Marco; Sebastian Brandner; John Collinge; Peter-Christian Klöhn
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

9.  Characterization of human plasma-derived exosomal RNAs by deep sequencing.

Authors:  Xiaoyi Huang; Tiezheng Yuan; Michael Tschannen; Zhifu Sun; Howard Jacob; Meijun Du; Meihua Liang; Rachel L Dittmar; Yong Liu; Mingyu Liang; Manish Kohli; Stephen N Thibodeau; Lisa Boardman; Liang Wang
Journal:  BMC Genomics       Date:  2013-05-10       Impact factor: 3.969

10.  Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles.

Authors:  Vincenzo Mattei; Maria Grazia Barenco; Vincenzo Tasciotti; Tina Garofalo; Agostina Longo; Klaus Boller; Johannes Löwer; Roberta Misasi; Fabio Montrasio; Maurizio Sorice
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more
  24 in total

Review 1.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

Review 2.  Cellular mechanisms responsible for cell-to-cell spreading of prions.

Authors:  Didier Vilette; Josquin Courte; Jean Michel Peyrin; Laurent Coudert; Laurent Schaeffer; Olivier Andréoletti; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2018-05-14       Impact factor: 9.261

3.  Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time.

Authors:  Christiane Muth; Katharina Schröck; Charlotte Madore; Kristin Hartmann; Zain Fanek; Oleg Butovsky; Markus Glatzel; Susanne Krasemann
Journal:  Brain Pathol       Date:  2016-11-21       Impact factor: 6.508

Review 4.  Extracellular vesicles with diagnostic and therapeutic potential for prion diseases.

Authors:  Arun Khadka; Jereme G Spiers; Lesley Cheng; Andrew F Hill
Journal:  Cell Tissue Res       Date:  2022-04-08       Impact factor: 5.249

Review 5.  Extracellular Vesicles and Neurodegenerative Diseases.

Authors:  Andrew F Hill
Journal:  J Neurosci       Date:  2019-11-20       Impact factor: 6.167

Review 6.  The Potential of Liquid Biopsy of the Brain Using Blood Extracellular Vesicles: The First Step Toward Effective Neuroprotection Against Neurodegenerative Diseases.

Authors:  Hanin Abdel-Haq
Journal:  Mol Diagn Ther       Date:  2020-09-25       Impact factor: 4.074

Review 7.  Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications.

Authors:  Julieta De Toro; Leticia Herschlik; Claudia Waldner; Claudia Mongini
Journal:  Front Immunol       Date:  2015-05-04       Impact factor: 7.561

8.  Detection of cellular prion protein in exosomes derived from ovine plasma.

Authors:  Elena Berrone; Cristiano Corona; Maria Mazza; Elena Vallino Costassa; Monica Lo Faro; Francesca Properzi; Chiara Guglielmetti; Cristiana Maurella; Maria Caramelli; Maria Chiara Deregibus; Giovanni Camussi; Cristina Casalone
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

Review 9.  Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions.

Authors:  Gabriella Schiera; Carlo Maria Di Liegro; Italia Di Liegro
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

Review 10.  Extracellular vesicles from infected cells: potential for direct pathogenesis.

Authors:  Angela Schwab; Shabana S Meyering; Ben Lepene; Sergey Iordanskiy; Monique L van Hoek; Ramin M Hakami; Fatah Kashanchi
Journal:  Front Microbiol       Date:  2015-10-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.